Metraipolis › archive › dc_b5a09bbbaa77

Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes… — Europe PMC PMID:41136748

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41136748
DOI
10.1007/s00277-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-09T01:38:21.931Z
SHA-256 of the archived text
407fb0b4c9704eff6be83db205b5d2390e190134d21da7581e27b18ef06ffc60
Stable URL of this page
https://metraipolis.com/documento/dc_b5a09bbbaa77

How to cite

Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes… — Europe PMC PMID:41136748 — Europe PMC (en), https://europepmc.org/article/MED/41136748 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b5a09bbbaa77 (Metraipolis archive dc_b5a09bbbaa77, sha256 407fb0b4c9704eff6be83db205b5d2390e190134d21da7581e27b18ef06ffc60)
BibTeX
@misc{dcb5a09bbbaa77,
  title = {Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes… — Europe PMC PMID:41136748},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41136748},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b5a09bbbaa77; sha256 407fb0b4c9704eff6be83db205b5d2390e190134d21da7581e27b18ef06ffc60},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41136748. Agents can read the archived copy with the MCP tool read_document.